Scholarlink

Aim <p>Examine racial and ethnic inequities in hepatitis C and B virus (HCV and HBV) screening across high-risk populations.</p> Subject and Methods <p>Chronic HCV and HBV infections can lead to cirrhosis, hepatocellular carcinoma (HCC), and death. Despite universal screening recommendations, &lt; 50% of US adults are tested for these viruses. Populations with lower socio-economic status experience higher rates of viral-related cirrhosis and HCC, which may be reduced through screening and treatment. This study analyzed data from 91,875 patients (2019–2021) at the Health Choice Network, a federally qualified health center in Florida. Logistic regression assessed the determinants of HCV and HBV screening, considering factors such as age, sex, language, and race/ethnicity.</p> Results <p>The study population was predominantly female, Hispanic, uninsured, and living below the federal poverty line. Overall, 61.7% had HCV screening, and 43.7% had HBV screening. Haitian Creole-speaking patients (aOR 1.67; 95% CI, 1.50–1.85), Asian (aOR 1.41; 95% CI, 1.26–1.58), Spanish-speaking Hispanic (aOR 1.38; 95% CI, 1.32–1.44), and English-speaking Hispanic patients (aOR 1.12; 95% CI, 1.07–1.18) had higher odds of HCV screening, compared to NH-Whites. Similarly, Haitian Creole-speaking (aOR 1.91; 95% CI, 1.73–2.12), Asian (aOR 1.50; 95% CI, 1.33–1.68), and Spanish-speaking Hispanic patients (aOR 1.23; 95% CI, 1.17–1.29) had higher odds of HBV screening.</p> Conclusion <p>For an underserved population context, screening rates were above average, with higher prevalence among historically disadvantaged populations. However, rates remained suboptimal, particularly among NH-Whites, who account for the largest number of HCV-related liver cancers, often linked to injection drug use. Increasing screening, especially among NH-Whites and English-speaking Hispanics for HCV, is crucial for early diagnosis, treatment, and reducing severe liver disease risk, including cirrhosis and HCC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Chronic Viral Hepatitis Screening Inequities Across Florida Federally Qualified Health Centers

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月6日

查看全文
  • Hannah M. Cranford,
  • Daniel Parras,
  • Patricia D. Jones,
  • Edelise Endemano,
  • Katherine Chung-Bridges,
  • Paulo S. Pinheiro

摘要

Aim

Examine racial and ethnic inequities in hepatitis C and B virus (HCV and HBV) screening across high-risk populations.

Subject and Methods

Chronic HCV and HBV infections can lead to cirrhosis, hepatocellular carcinoma (HCC), and death. Despite universal screening recommendations, < 50% of US adults are tested for these viruses. Populations with lower socio-economic status experience higher rates of viral-related cirrhosis and HCC, which may be reduced through screening and treatment. This study analyzed data from 91,875 patients (2019–2021) at the Health Choice Network, a federally qualified health center in Florida. Logistic regression assessed the determinants of HCV and HBV screening, considering factors such as age, sex, language, and race/ethnicity.

Results

The study population was predominantly female, Hispanic, uninsured, and living below the federal poverty line. Overall, 61.7% had HCV screening, and 43.7% had HBV screening. Haitian Creole-speaking patients (aOR 1.67; 95% CI, 1.50–1.85), Asian (aOR 1.41; 95% CI, 1.26–1.58), Spanish-speaking Hispanic (aOR 1.38; 95% CI, 1.32–1.44), and English-speaking Hispanic patients (aOR 1.12; 95% CI, 1.07–1.18) had higher odds of HCV screening, compared to NH-Whites. Similarly, Haitian Creole-speaking (aOR 1.91; 95% CI, 1.73–2.12), Asian (aOR 1.50; 95% CI, 1.33–1.68), and Spanish-speaking Hispanic patients (aOR 1.23; 95% CI, 1.17–1.29) had higher odds of HBV screening.

Conclusion

For an underserved population context, screening rates were above average, with higher prevalence among historically disadvantaged populations. However, rates remained suboptimal, particularly among NH-Whites, who account for the largest number of HCV-related liver cancers, often linked to injection drug use. Increasing screening, especially among NH-Whites and English-speaking Hispanics for HCV, is crucial for early diagnosis, treatment, and reducing severe liver disease risk, including cirrhosis and HCC.